Contract notice: Pharmaceutical products Tender, Denmark - 42697281

Procurement Summary

Country : Denmark

Summary : Contract notice: Pharmaceutical products

Deadline : 19 Jun 2020

Other Information

Notice Type : Tender

TOT Ref.No.: 42697281

Document Ref. No. : 211672-2020

Competition : ICB

Financier : Self Financed

Purchaser Ownership : -

Tender Value : Refer Document

Purchaser's Detail

Purchaser : AMGROS I/S
Office Name: Amgros I/S
Address: Dampfærgevej 22
Town: Copenhagen
Postal Code: 2100
Contact Point: Flemming Sonne

Phone: +45 88713000
Fax: +45 88713008
Denmark
Email :udbud@amgros.dk
URL :http://www.amgros.dk

Tender Details

Object of the contract
Pharmaceutical products

Description: Contract notice: Pharmaceutical products

Authority Type: Body governed by public law
Contact Nature: Supplies
Procedure: Open procedure
Document: Contract notice
Regulation: European Union, with participation by GPA countries
Award criteria: Lowest price
CPV code: 33600000, 33600000, 33600000
CPV Description: Pharmaceutical products.

Amgros 2021-1.903.a.

Amgros is a partnership with the 5 regions as stakeholders. With a view to supplying the stakeholders` hospital pharmacies with medicines and the resale of individual stakeholders to the Faroe Islands and Greenland, Amgros I / S wishes to enter into framework agreements for the medicines specified in section II.2.4. The framework agreements are non-exclusive. Amgros I / S reseller lowthe funds for the hospital pharmacists for Amgros I / S` purchase price with a supplement. Framework agreements are entered into without purchase obligation and the hospital pharmacies in the regions are not obliged to use Amgros` framework agreements.

ATC Code: B01AC13,

Generic name: Abciximab,

Dispensing form: Injection and infusion, dissolution,

Strength: 2 mg / ml,

Unit value: 25 mg,

Quantity in units: 82.

The drugs listed above are offered independently by the medicinal products under the other tender numbers.

Each tender number is considered to be an independent part contract. A supplier will thus be able to choose to tender for one, several or all tender numbers, and the award will be made separately.t for each tender number. Reference is made to the terms of the contract, including the submission of tenders under the individual contract numbers. The suppliers must match this. The reason for this is that these are medicines for patient treatmentat public hospitals where the patient`s needs must be met. For a more detailed description, see section. VI.3, clause no. 3.6 and the framework agreement clause. 2. The medicinal products must have a marketing authorization valid for Denmark no later than 1 September 2020 at. 12.00. Furthermore, at the time of the expiry of the offer period and during the duration of the framework agreement, the supplier must have tenLicensing for the manufacture, import or wholesale of pharmaceuticals within the EU / EEA.

Suppliers wishing to submit tenders must use the standard European Common Procurement Document (ESPD) form to submit declaration of mandatory exclusion grounds in -- 135-136 of the Public Procurement Act (Act No. 1564 of 15 December 2015, as amended). Details of completion andapplication of the ESPD in the tendering process can be found in the guide drawn up by Amgro on this and in the Competition and Consumer Agency`s "Guide to the single European procurement document". The winning supplier (s) which Amgros intends to award to the Framework Agreement must, before the award, have made documentation available to Amgros as to the compulsory exclusiongrounds, cf. -- 152 - 153 of the Tendering Act. Amgros cannot exclude a supplier that is covered by one or more of the compulsory grounds for exclusion in -- 135-136 of the Procurement Act, provided that the supplier can provide sufficient evidence that the supplier is in fact reliable, cf. section 138 of the Procurement Act. Amgros reserves the right to carry out such a "self-cleaning" process, to say the leastthe math would be relevant.

No information required. II.2.3 Please note that a list of places of delivery is available on Amgros` supplier and supply portal:

https: //levportal.amgros.dk

The list is updated on an ongoing basis, as there are minor changes. II.2.4 it should be noted that Amgros has considered whether the subdivision can be further subdivided. Amgros has sk0This is not the case on the basis of considerations of economies of scale that will not be realized by a further breakdown as well as costs and patient safety considerations related to the subsequent contract and drug handling. II.1.5 and par. II.2.6 it should be noted that the value stated in clause. II.1.5 is the total value quoted for all tender numbersre (sub-agreements) for the duration of the framework agreement incl. possibility of extension, cf. II.2.7. In par. II.2.6 is the listed value for each tender number incl. option for extension specified, cf. II.2.7. It should also be noted that the quoted value is calculated on the basis of the AIP (list price) for the specific packages which form the basis of the stated "quantity in units" in paragraph. II.2.4, and at the actual purchase may therefore differ materially therefrom, cf. II.2.4, the terms of the contract. 3.6 and the framework agreement clause. 2. Questions regarding the tender documents must be submitted in the tender system, cf. the terms of the tender specifications. There may be some handling days associated with useand it is therefore incumbent upon any bidders to ensure this in good time. Reference is made to information related to the tender system, including the user manual. IV.2.4 it should be noted that some parts of the offer may also be in English. Please refer to clause no. 4.1. Note that electronic invoicing is required
Internet address (URL): http://www.amgros.dk

Documents

 Tender Notice